Objective: To retrospectively evaluate the safety and efficacy of flexible ureteroscopy (FURS) in combination with holmium laser lithotripsy for the treatment of bilateral upper urinary calculi. Materials and Methods: The stone-free status was defined as the absence of any stones or asymptomatic status, or the presence of clinically insignificant residual fragments <4 mm, and was assessed by plain kidney, ureter, and bladder X-ray. The operative time, stone-free rates (SFRs), serum creatinine (SCr), and complications were recorded. Results: During the operation, there was no bleeding, ureteral perforation, avulsion, and rupture. Postoperative hematuria was observed in 2 patients. SCr increased significantly on the first day after the procedure compared with the preoperative SCr, but after 4 weeks, the renal function significantly improved (p < 0.05). The SFR was 71.6% (63/88) on the first day after the first surgical procedure; it then increased to 86.4% (76/88) in the fourth week, and rose to 97.4% (76/78) after the second operation. Conclusion: The results demonstrated that FURS in combination with holmium laser lithotripsy represented a favorable less-invasive alternative with high SFR and acceptable complication rates in the treatment of bilateral upper urinary tract calculi.

1.
Rukin NJ, Siddiqui ZA, Chedgy EC, Somani BK: Trends in upper tract stone disease in England: evidence from the hospital episodes statistics database. Urol Int 2016, Epub ahead of print.
2.
Türk C, Knoll T, Petrik A: Guidelines on Urolithiasis. European Association of Urology, 2014.
3.
Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr: Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 2005;173:1991-2000.
4.
Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck AC, Gallucci M, Knoll T, Lingeman JE, Nakada SY, Pearle MS, et al: 2007 guideline for the management of ureteral calculi. Eur Urol 2007;52:1610-1631.
5.
Michel MS, Trojan L, Rassweiler JJ: Complications in percutaneous nephrolithotomy. Eur Urol 2007;51:899-906; discussion 906.
6.
Singh P, Yadav S, Singh A, Saini AK, Kumar R, Seth A, Dogra PN: Systemic inflammatory response syndrome following percutaneous nephrolithotomy: assessment of risk factors and their impact on patient outcomes. Urol Int 2016;96:207-211.
7.
Wen CC, Nakada SY: Treatment selection and outcomes: renal calculi. Urol Clin North Am 2007;34:409-419.
8.
Breda A, Ogunyemi O, Leppert JT, Lam JS, Schulam PG: Flexible ureteroscopy and laser lithotripsy for single intrarenal stones 2 cm or greater - is this the new frontier? J Urol 2008;179:981-984.
9.
Hyams ES, Munver R, Bird VG, Uberoi J, Shah O: Flexible ureterorenoscopy and holmium laser lithotripsy for the management of renal stone burdens that measure 2 to 3 cm: a multi-institutional experience. J Endourol 2010;24:1583-1588.
10.
Hussain M, Acher P, Penev B, Cynk M: Redefining the limits of flexible ureterorenoscopy. J Endourol 2011;25:45-49.
11.
Preminger GM: Management of lower pole renal calculi: shock wave lithotripsy versus percutaneous nephrolithotomy versus flexible ureteroscopy. Urol Res 2006;34:108-111.
12.
Grasso M: Ureteropyeloscopic treatment of ureteral and intrarenal calculi. Urol Clin North Am 2000;27:623-631.
13.
El-Hefnawy AS, El-Nahas AR, El-Tabey NA, Shoma AM, El-Assmy AM, El-Kenawy MR, El-Kappany HA, Eraky I: Bilateral same-session ureteroscopy for treatment of ureteral calculi: critical analysis of risk factors. Scand J Urol Nephrol 2011;45:97-101.
14.
Camilleri J, Schwalb DM, Eshghi M: Bilateral same session ureteroscopy. J Urol 1994;152:49-52.
15.
Deliveliotis C, Picramenos D, Alexopoulou K, Christofis I, Kostakopoulos A, Dimopoulos C: One-session bilateral ureteroscopy: is it safe in selected patients? Int Urol Nephrol 1996;28:481-484.
16.
Conlin MJ, Marberger M, Bagley DH: Ureteroscopy: development and instrumentation. Urol Clin North Am 1997;24:25-42.
17.
Tiselius H, Ackermann D, Alken P, Buck C, Conort P, Gallucci M: Guidelines on Urolithiasis. Eur Urol 2001;40:362-371.
18.
Bandi G, Vicentini FC, Triest JA: Anuric renal failure after same-session bilateral atraumatic flexible ureteroscopy. Int Braz J Urol 2007;33:193-194.
19.
Silverstein AD, Terranova SA, Auge BK, Weizer AZ, Delvecchio FC, Pietrow PK, Munver R, Albala DM, Preminger GM: Bilateral renal calculi: assessment of staged v synchronous percutaneous nephrolithotomy. J Endourol 2004;18:145-151.
20.
Holman E, Salah MA, Tóth C: Comparison of 150 simultaneous bilateral and 300 unilateral percutaneous nephrolithotomies. J Endourol 2002;16:33-36.
21.
Perry KT, Smith ND, Weiser AC, User HM, Kundu SD, Nadler RB: The efficacy and safety of synchronous bilateral extracorporeal shock wave lithotripsy. J Urol 2000;164(3 pt 1):644-647.
22.
Huang Z, Fu F, Zhong Z, Zhang L, Xu R, Zhao X: Flexible ureteroscopy and laser lithotripsy for bilateral multiple intrarenal stones: is this a valuable choice? Urology 2012;80:800-804.
23.
Riley JM, Stearman L, Troxel S: Retrograde ureteroscopy for renal stones larger than 2.5 cm. J Endourol 2009;23:1395-1398.
24.
Bader M, Gratzke C, Walther S, Weidlich P, Staehler M, Seitz M, Sroka R, Reich O, Stief CG, Schlenker B: Efficacy of retrograde ureteropyeloscopic holmium laser lithotripsy for intrarenal calculi >2 cm. Urol Res 2010;38:397-402.
25.
Wiesenthal JD, Ghiculete D, D'A Honey RJ, Pace KT: A comparison of treatment modalities for renal calculi between 100 and 300 mm2: are shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy equivalent? J Endourol 2011;25:481-485.
26.
Bozkurt OF, Resorlu B, Yildiz Y, Can CE, Unsal A: Retrograde intrarenal surgery versus percutaneous nephrolithotomy in the management of lower-pole renal stones with a diameter of 15 to 20 mm. J Endourol 2011;25:1131-1135.
27.
Atis G, Koyuncu H, Gurbuz C, Yencilek F, Arikan O, Caskurlu T: Bilateral single-session retrograde intrarenal surgery for the treatment of bilateral renal stones. Int Braz J Urol 2013;39:387-392.
28.
Aboumarzouk OM, Monga M, Kata SG, Traxer O, Somani BK: Flexible ureteroscopy and laser lithotripsy for stones >2 cm: a systematic review and meta-analysis. J Endourol 2012;26:1257-1263.
29.
Zhang Y, Yu CF, Jin SH, Zhu H, Na YQ: A prospective comparative study between minimally invasive percutaneous nephrolithotomy in supine position and flexible ureteroscopy in the management of single large stone in the proximal ureter. Urology 2014;83:999-1002.
30.
Aboumarzouk OM, Somani BK, Monga M: Flexible ureteroscopy and holmium: YAG laser lithotripsy for stone disease in patients with bleeding diathesis: a systematic review of the literature. Int Braz J Urol 2012;38:298-306; discussion 306.
31.
Gupta PK: Is the holmium: YAG laser the best intracorporeal lithotripter for the ureter? A 3-year retrospective study. J Endourol 2007;21:305-309.
32.
Auge BK, Pietrow PK, Lallas CD, Raj GV, Santa-Cruz RW, Preminger GM: Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol 2004;18:33-36.
33.
Schwalb D, Eshghi M, Davidian M, Franco I: Morphological and physiological changes in the urinary tract associated with ureteral dilation and ureteropyeloscopy: an experimental study. J Urol 1993;149:1576-1585.
34.
Khalaf IM, Shokeir AA, El-Gyoushi FI, Amr HS, Amin MM: Recoverability of renal function after treatment of adult patients with unilateral obstructive uropathy and normal contralateral kidney: a prospective study. Urology 2004;64:664-668.
35.
Tanriverdi O, Yencilek F, Koyuncu H, Yencilek E, Sarica K: Emergent stenting after uncomplicated ureteroscopy: evaluation of 23 patients. Urology 2011;77:305-308.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.